Lyora Therapeutics

Private

Belmont, MassachusettsHealthcare & Life Scienceshttps://www.lyoratx.com/

Last Round

Pre Seed

Jul 14, 2026

Total Funding Raised

$3.03M

Company Overview

Lyora Therapeutics is a biotechnology company developing a portfolio of genetic medicines targeting the root causes of inherited retinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyinherited retinal diseasesIRDCRISPRgene editingretinitis pigmentosaUsher syndromegene augmentationbiotech startupophthalmic medicinegenetic medicineorphan drugrare disease therapypreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lyora Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Lyora Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lyora Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Jul 14, 2026
Early Funding	Mar 11, 2025

View all Funding Rounds

Lyora Therapeutics Investors

Notable investors and investment history

Lyora Therapeutics investors
Investor	Rounds
Rhode Island Life Science Hub	Pre Seed

View all Investors

Lyora Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Lyora Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lyora Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelmont, Massachusetts

Employee Range1

Year Founded2026

Last FundingJul 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.